Compounds > 1-methyl-3-isobutylxanthine
Page last updated: 2024-10-29

1-methyl-3-isobutylxanthine and Leukemia, Megakaryocytic

1-methyl-3-isobutylxanthine has been researched along with Leukemia, Megakaryocytic in 1 studies

1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Deguine, V1
Kerbiriou-Nabias, D1
Lecoq, D1
Greenberg, SM1
Meyer, D1
Dosne, AM1

Other Studies

1 other study available for 1-methyl-3-isobutylxanthine and Leukemia, Megakaryocytic

ArticleYear
Cyclic adenosine monophosphate-dependent mechanisms induce von Willebrand factor expression in the Dami megakaryoblastic cell line.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 1995, Volume: 6, Issue:1

    Topics: 1-Methyl-3-isobutylxanthine; Aneuploidy; Bucladesine; Colforsin; Cyclic AMP; Fluorescent Antibody Te

1995